Spectranetics hired Stacy McMahan as its new Chief Financial Officer, starting Sept. 28, according to a press release sent out by the medical-device company headquartered in Colorado Springs.
McMahan replaces long-time CFO Guy Childs, and will report directly to Spectranetics’ CEO, Scott Drake.
According to the release, McMahan has more than 25 years’ experience in finance leadership, including CFO and vice president of finance positions for high-profile public companies. She is leaving a job as senior vice president, CFO and treasurer of MSA Safety Inc. Before that, she worked at Thermo Fisher Scientific, where she was a vice president of finance for the customer channels group. She’s held a similar position with Johnson & Johnson and Eli Lilly.
“Stacy is a proven executive with world-class finance, operations and business development experience,” said Drake in the release. “In addition to her financial background and prior experience with large, publicly held companies, Stacy brings a deep understanding of the medical device industry to this critical role. Her skills and leadership will help us capitalize on the transformational opportunities ahead. I am confident that, with the benefit of Guy Childs’ continued contribution and leadership, there will be a seamless transition as we execute our strategic plan.”
McMahan earned a Bachelor of Science Degree in finance from Oklahoma State University and a Master of Business Administration from Harvard Business School.
She arrives at Spectranetics as the company is recovering from a sharp down turn in their stock prices. To read more about their market struggles, click here.